Comment: Plateaus and reversals in ALS disease course or limitations of trial design?

Neurology. 2016 Mar 1;86(9):811. doi: 10.1212/WNL.0000000000002365. Epub 2016 Jan 22.

Authors

Ruben P A van Eijk¹, Leonard H van den Berg¹

Affiliation

¹ From the Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, the Netherlands.

PMID: 26802092
DOI: 10.1212/WNL.0000000000002365

No abstract available

Publication types

Comment

MeSH terms

Amyotrophic Lateral Sclerosis / diagnosis*
Amyotrophic Lateral Sclerosis / epidemiology*
Clinical Trials as Topic / statistics & numerical data*
Humans
Registries*
Remission, Spontaneous*